09:16 AM EDT, 03/19/2025 (MT Newswires) -- Orthofix Medical ( OFIX ) said Wednesday that it has received the US Food and Drug Administration's 510(k) clearance and European CE Mark approval for its TrueLok Elevate transverse bone transport system used in limb preservation procedures.

The system, designed to treat bone and soft tissue defects, is currently available in a limited market release in the US and select international markets, the medical technology company said.

Shares of the company were up more than 1% in recent Wednesday premarket activity.